Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | Bcr |
| Gene Name: | BCR |
| Protein Full Name: | Breakpoint cluster region protein |
| Alias: | ALL; BCR; BCR1; Breakpoint cluster region; CML; D22S11; D22S662; PHL; Renal carcinoma antigen NY-REN-26 |
| Mass (Da): | 142819 |
| Number AA: | 1271 |
| UniProt ID: | P11274; Q12843; Q12845; Q12848; Q14020; Q13846 |
| Locus ID: | 613 |
| COSMIC ID: | BCR |
| Gene location on chromosome: | 22q11.2 |
| Cancer protein type: | UNCLEAR |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | UNCLEAR |
| Number of cancer specimens: | 20651 |
| Percent of cancer specimens with mutations: | 0.82 |
| Deregulated in translocations: | t(9;22)(q34;q11): BCR-ABL; t(8;22)(p11;q11): BCR-FGFR1; t(4;22)(q12;q11): BCR-PDGFRA; t(9;22)(p24;q11): BCR-JAK2 |
| Normal role description: | BCR is a protein-serine/threonine kinase - Atypical. Bcr and abl fusion protein triggers unregulated cell growth. The function of physiological BCR remains unclear. |